Areas of Activity

Contact us

30 May 2018

Dr. Ranjith Ramasamy Reports on First Clinical Trials Using Shockwave Therapy to Treat ED

Ranjith Ramasamy, M.D., assistant professor of urology and director of reproductive urology at the University of Miami Miller School of Medicine, spoke recently before members of the American Urological Association at its annual convention in San Francisco. His presentation was a summary of randomized clinical trials he conducted on the effects of shockwave therapy for treating erectile dysfunction (ED), a chronic condition that affects 30 million men in the U.S.

A specialist in treating male infertility and sexual dysfunction disorders, Ramasamy's initial findings show that shockwave therapy has the potential to effectively treat ED through the use of Renova-ED (MoreNova by DirexGroup), an innovative linear (low-intensity) shockwave device that has improved erectile function in some cases. Current treatments attempt to improve ED without treating its underlying pathophysiology.

Dr. Ramasamy's presentation focused on his findings regarding the safety and efficacy of this new type of treatment. Shockwave therapy for ED differs from ESWL (Extracorporeal Shockwave Lithotripsy) used on patients with kidney stones in a variety of ways, the most prominent of which is that the energy volume generated by Renova-ED (MoreNova by DirexGroup), is lower and incorporates dual applicators delivering simultaneous Linear Shockwaves to the whole treated region.
According to the urologist and micro-surgeon, linear shockwave therapy can increase blood flow to the penis and "recruit" or harvest stem cells that enable men suffering from ED to have better erections. The best candidates for this type of therapy are men who have not tried any therapy medications or those who have already tried Viagra or Cialis.

The FDA has yet to approve shockwave therapy for ED, and the Miller School is currently conducting a clinical trial in the U.S. using this treatment.

About DirexGroup:
DirexGroup specializes in introducing innovative high-technology devices for urologists in all worldwide markets. DirexGroup, established 35 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs. Our products are characterized by reliability, modularity and transportability combined with cost effectiveness and ease of use. A worldwide network of committed service centers assures competent support and maintenance. Contact DirexGroup at: This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact Us

© 2024 DirexGroup. All Rights Reserved.